121 followers
✅This work sets the basis for the first class of hybrid AR inhibitors which successfully combine two drug moieties – EPI-001 and enzalutamide – into the same molecule. https://t.co/kdkdobOvrn https://t.co/vrNaaUaRTB
✅This work sets the basis for the first class of hybrid AR inhibitors which successfully combine two drug moieties – EPI-001 and enzalutamide – into the same molecule. https://t.co/kdkdobOvrn https://t.co/vrNaaUaRTB
Well done and congrats @RaduNicolescu4 !!! Just the first of many to come!! 🙌🏻 Thank you also to our collaborators from @UniOfSurrey
RT @ChemMedChem: Hybrid Androgen Receptor Inhibitors Outperform Enzalutamide and EPI-001 in in vitro Models of Prostate Cancer Drug Resista…
RT @ChemMedChem: Hybrid Androgen Receptor Inhibitors Outperform Enzalutamide and EPI-001 in in vitro Models of Prostate Cancer Drug Resista…